CureVac N.V. Profit Margin

The latest profit margin for CVAC is 37.93% as of November 2025. That compares with 20.29% in the prior-year period — up 86.9% year over year. That is above the Healthcare sector average of 14.41%. Investors often review this figure alongside CureVac N.V.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CVAC's profit margin moved from 20.29% to 37.93% — a 86.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CureVac N.V.'s valuation or profitability profile.

Against Healthcare companies, CVAC currently prints 37.93% for profit margin, while the sector average sits near 14.41%. That is roughly 163.1% above the sector mean. Large gaps often invite a closer look at CureVac N.V.'s growth, margins, and balance sheet.

Profit Margin shows how effectively CureVac N.V. converts resources into returns. At 37.93%, CVAC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 20.29% in the prior-year period — up 86.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CVAC's profit margin (37.93%), review year-over-year change from 20.29%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.